The reliability of routine clinical post-processing software in assessing potential diffusion-weighted MRI “biomarkers” in brain metastases
Authors:
- 27 December 2013
- journal article
- case report
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 32 (3) , 291-296
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Does Suspicion of Prostate Cancer on Integrated T2 and Diffusion-weighted MRI Predict More Adverse Pathology on Radical Prostatectomy?Urology, 2013
- Differentiation between high and low grade tumours in paediatric patients by using apparent diffusion coefficientsEuropean Journal of Paediatric Neurology, 2013
- Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival TimesPLOS ONE, 2013
- Diffusion weighted imaging (DWI) of the breast: Ready for clinical practice?European Journal of Radiology, 2012
- Diffusion‐weighted MRI in rectal cancer: Apparent diffusion coefficient as a potential noninvasive marker of tumor aggressivenessJournal of Magnetic Resonance Imaging, 2012
- Imaging biomarkers of brain tumour margin and tumour invasionBritish Journal of Radiology, 2011
- Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapyEuropean Journal of Cancer, 2011
- Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System LymphomaAmerican Journal of Neuroradiology, 2009
- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and RecommendationsNeoplasia, 2009
- Brain metastases: Histology, multiplicity, surgery, and survivalCancer, 1996